ViAqua Therapeutics is the developer of an orally administered treatment designed to improve health management and prevent viral epidemics in aquaculture. The company's first product is designed for use in shrimp, which comprises 20% of the total international trade value of fish products. ViAqua's platform for health management in shellfish and fish utilizes a proprietary RNAi formulation that triggers the immune system and prevents viral infections. The coated particles are delivered via feed to produce the maximum effect and reduce cost.